Status:
RECRUITING
Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes
Lead Sponsor:
iRxReminder
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Tardive Dyskinesia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia.
Detailed Description
The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia. Participants will all be taking an antipsychotic medication and half will have a diagnosis of Tardi...
Eligibility Criteria
Inclusion
- For the non-TD group:
- Prescribed and taking an antipsychotic medication for 90-days or longer.
- Tardive Dyskinesia symptoms if present are not from Parkinsons, Tourette's syndrome, Huntington disease.
- Signed an informed consent.
- Speaks English fluently.
Exclusion
- Suffered a moderate or severe head injury in the last year;
- History of a learning disorder or developmental disability that would inhibit a patient from completing the TD protocol.
- Severe visual impairment that is cannot be corrected by glasses or contacts.
Key Trial Info
Start Date :
May 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06011408
Start Date
May 30 2023
End Date
December 31 2024
Last Update
March 12 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fermata Helath
Brooklyn, New York, United States, 10038
2
Charak Research Center
Garfield Heights, Ohio, United States, 44125